U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1997
189
Name Type Language
DACLIZUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
RO 24-7375
Preferred Name English
DACLIZUMAB [USAN]
Common Name English
Daclizumab [WHO-DD]
Common Name English
DACLIZUMAB [VANDF]
Common Name English
DACLIZUMAB [MART.]
Common Name English
daclizumab [INN]
Common Name English
RO-24-7375
Code English
DACLIZUMAB [PURPLE BOOK CDER]
Common Name English
DACLIXIMAB
Common Name English
DACLIZUMAB [EMA EPAR]
Common Name English
DACLIZUMAB [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C574
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175621
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
WHO-ATC L04AC01
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
LIVERTOX NBK548018
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175622
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000175621
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
WHO-VATC QL04AC01
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: GRAFT REJECTION)
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
FDA ORPHAN DRUG 67692
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
EMA ASSESSMENT REPORTS ZENAPAX (WITHDRAWN: KIDNEY TRANSPLANTATION)
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
NDF-RT N0000010279
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
FDA ORPHAN DRUG 67792
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
Code System Code Type Description
RXCUI
190353
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY RxNorm
MERCK INDEX
m4066
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY Merck Index
ChEMBL
CHEMBL1201605
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
NCI_THESAURUS
C1569
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
DRUG BANK
DB00111
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
FDA UNII
CUJ2MVI71Y
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
USAN
FF-43 2
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
LACTMED
Daclizumab
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
WIKIPEDIA
DACLIZUMAB
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
SMS_ID
100000085411
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
EVMPD
SUB06885MIG
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
CAS
152923-56-3
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
IUPHAR
6880
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
INN
7164
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
MESH
C096001
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
DRUG CENTRAL
4953
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108279
Created by admin on Mon Mar 31 20:46:02 GMT 2025 , Edited by admin on Mon Mar 31 20:46:02 GMT 2025
PRIMARY
ACTIVE MOIETY
DACLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966